Engineering Manager
Unlearn exists to transform clinical development by making every trial smarter.
Unlearn exists to transform clinical development by making every trial smarter. We harness data, AI, and digital twins to enable faster, more robust studies that bring life-saving treatments to patients faster. This mission drives everything we do as we partner with biopharmaceutical companies to redesign how clinical trials are planned, run, and analyzed.
We are defining the future of clinical development with unmatched scientific credibility, replacing uncertainty with AI-powered precision so decisions are clearer and trials are stronger. We don’t just disrupt the pharmaceutical industry, we create lasting change.
We believe AI will define the future of medicine, and we are committed to building that future responsibly, rigorously, and in close collaboration with our partners in clinical development.
ABOUT OUR TEAM
We come from a variety of backgrounds ranging from machine learning to marketing—but regardless of where we come from, Unlearners share some common traits:
Headquartered in San Francisco, Unlearn was founded in 2017 by a team of world-class machine learning scientists. We have raised venture capital from top tier investors such as Altimeter, Insight Partners, Radical Ventures, 8VC, DCVC, and DCVC Bio, and completed our $50 million Series C in January 2024.
If our purpose and culture resonate with you, we invite you
YOUR ROLE
Leading Pharma and Biotech companies trust Unlearn to deliver scientifically rigorous work using digital twins on studies where the stakes are high and the timelines are real. A digital twin of a patient is a comprehensive prediction of expected outcomes under a defined standard of care, made by a machine learning model built using our proprietary technology.
Working at scale across the industry requires a strong engineering foundation built around data, models, and AI in a regulated, compliance-heavy environment.
Posted September 17, 2026